Krug, David http://orcid.org/0000-0001-8811-5416
Vonthein, Reinhard
Schreiber, Andreas
Boicev, Alexander D.
Zimmer, Jörg
Laubach, Reinhold
Weidner, Nicola
Dinges, Stefan
Hipp, Matthias
Schneider, Ralf
Weinstrauch, Evelyn
Martin, Thomas
Hörner-Rieber, Juliane
Olbrich, Denise
Illen, Alicia
Heßler, Nicole
König, Inke R.
Dellas, Kathrin
Dunst, Jürgen
Funding for this research was provided by:
Deutsche Krebshilfe (110897)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Article History
Received: 26 September 2020
Accepted: 30 November 2020
First Online: 15 December 2020
Compliance with ethical guidelines
:
: D. Krug has received honoraria from Merck Sharp & Dome, outside of the submitted work. J. Hörner-Rieber received speaker fees and travel reimbursement from ViewRay Inc, as well as travel reimbursement form IntraOP Medical and Elekta Instrument AB outside the submitted work. R. Vonthein, A. Schreiber, A.D. Boicev, J. Zimmer, R. Laubach, N. Weidner, S. Dinges, M. Hipp, R. Schneider, E. Weinstrauch, T. Martin, D. Olbrich, A. Illen, N. Heßler, I.R. König, K. Dellas, and J. Dunst declare that they have no competing interests.
: Before start of enrollment, the trial protocol was approved by the leading ethics committee at the University of Lübeck (ID 12-163) and the respective ethics committee responsible for the individual participating sites. Written informed consent was provided by every patient before enrollment.